Outcomes of De Vega versus Biodegradable Ring Annuloplasty in the Surgical Treatment of Tricuspid Regurgitation (Mid-term Results)
Purpose: The aim of this study was to compare De Vega semicircular annuloplasty and a new biodegradable ring annuloplasty technique in patients requiring surgical intervention for tricuspid valve disease with concomitant disease of the mitral valve.
Methods: Between January 2004 and May 2008, 129 consecutive patients underwent annuloplasty procedures to correct tricuspid valve regurgitation during a concomitant mitral valve operation requiring replacement. Additionally, 24 patients underwent aortic valve replacement (AVR), 11 underwent coronary artery bypass grafting (CABG), 5 underwent AVR plus CABG, 3 underwent mitral valve replacement plus atrial septal defect (ASD) closure, and 2 underwent ASD closure. The patients in this study were assigned to 2 groups: Kalangos ring annuloplasty was performed in 67 patients (group 1), and De Vega semicircular annuloplasty was performed in the remaining 62 patients (group 2).
Results: Both tricuspid valve repair techniques produced a low rate of complications; however, the number of patients who developed residual tricuspid regurgitation was significantly lower in group 1.
Conclusion: The biodegradable ring annuloplasty technique may be used easily and safely in moderate and severe cases of tricuspid regurgitation; however, larger clinical series are necessary to confirm our promising results.
Blackstone EH, Kirklin JW, Pacifico AD. 1979. Decision-making in repair of tetralogy of Fallot based on intraoperative measurements of pulmonary arterial outflow tract. J Thorac Cardiovasc Surg 77:526-32.nBoyd AD, Engelman RM, Isom OV, Reed GE, Spencer FC. 1974. Tricuspid annuloplasty: five and one-half years' experience with 78 patients. J Thorac Cardiovasc Surg 68:344-51.nBreyer RH, McClenathan JH, Michaels LL, McIntosh CL, Morrow AG. 1976. Tricuspid regurgitation. A comparison of nonoperative management, tricuspid annuloplasty and tricuspid valve replacement. J Thorac Cardiovasc Surg 72:867-74.nCarpentier A, Deloche A, Hanania G, et al. 1974. Surgical management of acquired tricuspid valve disease. J Thorac Cardiovasc Surg 67:53-65.nCome PC, Riley MF. 1985. Tricuspid annular dilatation and failure of tricuspid leaflet coaptation in tricuspid regurgitation. Am J Cardiol 55:599-601.nDe Vega NG. 1972. Selective, adjustable and permanent annuloplasty. An original technic for the treatment of tricuspid insufficiency [in Spanish]. Rev Esp Cardiol 25:555-6.nEge E, Paç M. 2002. Tricuspid ve Pulmoner kapak hastaliklarinda cerrahi yakla?im. T Klin Kardiyol 15:136-41.nHaerten K, Sepiel L, Loogen F, Herzer J. 1978. Hemodynamic studies' after DeVega's tricuspid annuloplasty. Circulation 58:I28-33.nKalangos A, Sierra J, Vala D, et al. 2006. Annuloplasty for valve repair with a new biodegradable ring: an experimental study. J Heart Valve Dis 15:783-90.nKay JH, Maselli-Campagna G, Tsuji KK. 1965. Surgical treatment of tricuspid insufficiency. Ann Surg 162:53-8.nKay JH. 1992. Surgical treatment of tricuspid insufficiency. Ann Thorac Surg 53:1132-3.nKazaz M, Celkan MA, Ustunsoy H, Ba?pinar O. 2005. Mitral annuloplasty with biodegradable ring for infective endocarditis: a new tool for the surgeon for valve repair in childhood. Interact Cardiovasc Thorac Surg 4:378-80.nKing RM, Schaff HV, Danielson GK, et al. 1984. Surgery for tricuspid regurgitation late after mitral valve replacement. Circulation 70:I193-7.nPasque M, Williams WG, Coles JG, Trusler GA, Freedom RM. 1987. Tricuspid valve replacement in children. Ann Thorac Surg 44:164-8.nSimon R, Oelert H, Borst HG, Lichtlen PR. 1980. Influence of mitral valve surgery on tricuspid incompetence concomitant with mitral valve disease. Circulation 62:I152-7.nUluçay A, Tatli E. 2008. Myokart performans indeksi. Anadolu Kardiyol Derg 8:143-8.nYavuz S. 2007. Should stitch annuloplasty really be abandoned for developed flexible prosthetic band or ring in functional tricuspid regurgitation? Interact Cardiovasc Thorac Surg 6:736.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).